T1	PROC 46 78	Ensayo controlado y aleatorizado
T2	PROC 84 115	evaluar la seguridad y eficacia
T3	PROC 122 138	quimioprofilaxis
#1	AnnotatorNotes T3	C0282515; Chemoprevention; Therapeutic or Preventive Procedure
T4	DISO 167 190	infección por SARS CoV2
T5	DISO 326 334	COVID-19
#2	AnnotatorNotes T5	C5203670; COVID19 (disease); Disease or Syndrome
T6	DISO 300 324	Infección por SARS-CoV-2
#3	AnnotatorNotes T6	C5203670; COVID19 (disease); Disease or Syndrome
T7	DISO 253 258	COVID
T8	PROC 592 601	protocolo
#4	AnnotatorNotes T8	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T9	PROC 522 558	consentimiento informado por escrito
#5	AnnotatorNotes T9	C0811741; Obtain informed written consent; Health Care Activity
T10	DISO 757 787	Infección previa por SARS CoV2
T11	CHEM 924 927	HCQ
T12	PROC 816 829	Serología IgG
T13	CHEM 826 829	IgG
#6	AnnotatorNotes T13	C0020852; immunoglobulin G; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T14	DISO 880 894	sintomatología
#7	AnnotatorNotes T14	C3540840; Sign or Symptom; Finding
T15	PROC 901 912	Tratamiento
#8	AnnotatorNotes T15	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T16	CHEM 930 940	cloroquina
#9	AnnotatorNotes T16	C0008269; chloroquine; Organic Chemical · Pharmacologic Substance
T17	DISO 984 993	epilepsia
#10	AnnotatorNotes T17	C0014544; Epilepsy; Disease or Syndrome
T18	DISO 1004 1012	porfiria
#11	AnnotatorNotes T18	C0032708; Disorders of Porphyrin Metabolism; Disease or Syndrome | C0235387; Porphyria type syndrome; Disease or Syndrome
T19	DISO 1014 1035	cardiopatía isquémica
#12	AnnotatorNotes T19	C0151744; Myocardial Ischemia; Disease or Syndrome
T20	PROC 1051 1062	Tratamiento
#13	AnnotatorNotes T20	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T21	CHEM 1083 1093	tamoxifeno
#14	AnnotatorNotes T21	C0039286; tamoxifen; Organic Chemical · Pharmacologic Substance
T22	CHEM 1096 1106	raloxifeno
#15	AnnotatorNotes T22	C0244404; raloxifene; Organic Chemical · Pharmacologic Substance
T23	DISO 1112 1129	Enfermedad ocular
#16	AnnotatorNotes T23	C0015397; Disorder of eye; Disease or Syndrome
T24	DISO 1152 1163	maculopatía
#17	AnnotatorNotes T24	C0730362; Disorder of macula of retina; Disease or Syndrome
T25	DISO 1169 1191	Insuficiencia cardíaca
#18	AnnotatorNotes T25	C0018801; Heart failure; Disease or Syndrome
T26	DISO 1352 1358	cáncer
#19	AnnotatorNotes T26	C0006826; Malignant Neoplasms; Neoplastic Process
T27	ANAT 1368 1379	basocelular
#20	AnnotatorNotes T27	C0596155; Basal Cell; Cell
T28	DISO 1484 1590	enfermedad inmunológica, endocrina, hematológica, gastrointestinal, neurológica, neoplásica o psiquiátrica
T29	CHEM 1829 1832	HCQ
T30	PROC 1634 1640	tratar
#21	AnnotatorNotes T30	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T31	PROC 1646 1657	Anticuerpos
#22	AnnotatorNotes T31	C0201278; Antibody measurement; Laboratory Procedure
T32	DISO 1719 1746	Enfermedad renal o hepática
T33	ANAT 1738 1746	hepática
#23	AnnotatorNotes T33	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T34	DISO 1796 1813	Hipersensibilidad
#24	AnnotatorNotes T34	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T35	DISO 1816 1823	alergia
#25	AnnotatorNotes T35	C1527304; Allergic Reaction; Pathologic Function
T36	CHEM 143 160	hidroxicloroquina
#26	AnnotatorNotes T36	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T37	PROC 789 804	PCR coronavirus
#27	AnnotatorNotes T37	C5244035; SARS-CoV-2 PCR test; Laboratory Procedure | C5541700; PCR for SARS-CoV-2; Laboratory Procedure
T38	PROC 843 856	PCR SARS Cov2
#28	AnnotatorNotes T38	C5244035; SARS-CoV-2 PCR test; Laboratory Procedure | C5541700; PCR for SARS-CoV-2; Laboratory Procedure
T39	CHEM 979 982	HCQ
T40	ANAT 1123 1129	ocular
#29	AnnotatorNotes T40	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T41	ANAT 1183 1191	cardíaca
#30	AnnotatorNotes T41	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T42	PROC 1427 1451	consentimiento informado
#31	AnnotatorNotes T42	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T43	DISO 1676 1712	virus de la inmunodeficiencia humana
T44	ANAT 1730 1735	renal
#32	AnnotatorNotes T44	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T45	CHEM 1893 1896	HCQ
T46	Date 13 17	2020
T47	LIVB 194 212	personal sanitario
#33	AnnotatorNotes T47	C0018724; Health Personnel; Professional or Occupational Group | C1704312; Health Professional; Professional or Occupational Group
T48	LIVB 238 248	Sanitarios
#34	AnnotatorNotes T48	C0018724; Health Personnel; Professional or Occupational Group | C1704312; Health Professional; Professional or Occupational Group
T49	Neg_cue 249 252	sin
T50	LIVB 365 386	Profesional sanitario
#35	AnnotatorNotes T50	C0018724; Health Personnel; Professional or Occupational Group
T51	Age 408 434	entre los 18 y los 65 años
T52	Duration 670 693	las dos últimas semanas
T53	Duration 704 726	las siguientes semanas
T54	LIVB 793 804	coronavirus
#36	AnnotatorNotes T54	C5203676; SARS-CoV-2; Virus
T55	Neg_cue 857 865	negativa
T56	Neg_cue 868 879	ausencia de
T57	Date 913 919	actual
T58	Date 1036 1044	reciente
T59	Date 1072 1078	actual
T61	Neg_cue 1360 1367	excepto
T62	Duration 1384 1402	los últimos 5 años
T63	Neg_cue 1409 1417	Negativa
T65	Neg_cue 1630 1633	sin
T67	PHYS 1769 1777	Embarazo
#37	AnnotatorNotes T67	C0032961; Pregnancy; Organism Function
T68	PHYS 1780 1789	lactancia
#38	AnnotatorNotes T68	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T71	PHYS 1509 1518	endocrina
#39	AnnotatorNotes T71	C1286097; Endocrine observable; Organ or Tissue Function
T66	ANAT 1534 1550	gastrointestinal
#40	AnnotatorNotes T66	C0012240; Gastrointestinal system; Body System
T72	ANAT 1495 1507	inmunológica
#41	AnnotatorNotes T72	C0020962; Immune system; Body System | C1305754; Entire immune system; Body System
T69	LIVB 181 190	SARS CoV2
#42	AnnotatorNotes T69	C5203676; SARS-CoV-2; Virus
T73	LIVB 314 324	SARS-CoV-2
#43	AnnotatorNotes T73	C5203676; SARS-CoV-2; Virus
T74	LIVB 778 787	SARS CoV2
#44	AnnotatorNotes T74	C5203676; SARS-CoV-2; Virus
T75	LIVB 847 856	SARS Cov2
#45	AnnotatorNotes T75	C5203676; SARS-CoV-2; Virus
T60	DISO 1352 1358;1368 1379	cáncer basocelular
#46	AnnotatorNotes T60	C0007117; Basal cell carcinoma; Neoplastic Process
T64	PROC 1223 1282	clasificación de la Asociación de Cardiología de Nueva York
#47	AnnotatorNotes T64	C4706236; Assessment using New York Heart Association Classification; Health Care Activity
T70	PROC 1284 1310	New York Heart Association
#48	AnnotatorNotes T70	C4706236; Assessment using New York Heart Association Classification; Health Care Activity
T76	DISO 651 661	exposición
#49	AnnotatorNotes T76	C0260339; Encounter due to contact with or exposure to communicable diseases; Finding [ICD-10: Z20]
T77	Spec_cue 1457 1468	Indicios de
T78	PROC 475 494	visita de selección
#50	AnnotatorNotes T78	C1710477; Trial Screening; Research Activity + C1512346; Patient Visit; Health Care Activity
T79	Quantifier_or_Qualifier 467 474	primera
A1	Assertion T30 Negated
A2	Assertion T7 Negated
A3	Assertion T75 Negated
A4	Assertion T14 Negated
A5	Assertion T27 Negated
A6	Assertion T60 Negated
A7	Assertion T28 Speculated
A8	Assertion T42 Negated
A9	Status T10 History_of
A10	Assertion T39 Contraindicated
A11	Status T17 History_of
A12	Status T19 History_of
A13	Status T20 History_of
A14	Status T21 History_of
A15	Status T22 History_of
A16	Status T23 History_of
A17	Status T24 History_of
A18	Status T25 History_of
A19	Status T34 History_of
A20	Status T35 History_of
A21	Assertion T45 Contraindicated
A22	Status T18 History_of
#52	AnnotatorNotes T1	C0206035; Controlled Clinical Trials, Randomized; Research Activity
#53	AnnotatorNotes T2	C0511730; Identify product efficacy and safety issues; Health Care Activity
#54	AnnotatorNotes T4	C5203670; COVID19 (disease); Disease or Syndrome
#55	AnnotatorNotes T7	C5203670; COVID19 (disease); Disease or Syndrome
#56	AnnotatorNotes T11	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance 
#57	AnnotatorNotes T39	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance 
#58	AnnotatorNotes T43	C0458074; Human immunodeficiency virus (HIV) status; Finding
#59	AnnotatorNotes T32	C0023895; Liver diseases; Disease or Syndrome + C0022658; Kidney Diseases; Disease or Syndrome
#60	AnnotatorNotes T29	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
#61	AnnotatorNotes T45	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
#62	AnnotatorNotes T57	C0521116; Current (present time); Temporal Concept
#63	AnnotatorNotes T59	C0521116; Current (present time); Temporal Concept
#64	AnnotatorNotes T58	C0332185; Recent; Temporal Concept
T80	DISO 1314 1328	QTc prolongado
#51	AnnotatorNotes T80	C1560305; Prolonged QTc interval; Pathologic Function
R1	Location_of Arg1:T41 Arg2:T25	
T81	Result_or_Value 1202 1216	Grado III a IV
R2	Has_Result_or_Value Arg1:T64 Arg2:T81	
R3	Has_Result_or_Value Arg1:T70 Arg2:T81	
R4	Negation Arg1:T61 Arg2:T60	
R5	Location_of Arg1:T27 Arg2:T60	
R6	Negation Arg1:T61 Arg2:T60	
R7	Overlap Arg1:T26 Arg2:T62	
R8	Negation Arg1:T63 Arg2:T42	
#65	AnnotatorNotes T28	C0021053; Immune System Diseases; Disease or Syndrome | C0014130; Endocrine System Diseases; Disease or Syndrome | C0018939; Hematological Disease; Disease or Syndrome | C0017178; Gastrointestinal Diseases; Disease or Syndrome |   C0027765; nervous system disorder; Disease or Syndrome | C1882062; Neoplastic disease; Neoplastic Process | C0004936; Mental disorders; Mental or Behavioral Dysfunction
R9	Speculation Arg1:T77 Arg2:T28	
R10	Location_of Arg1:T72 Arg2:T28	
R12	Location_of Arg1:T66 Arg2:T28	
T82	Observation 1591 1600	inestable
#66	AnnotatorNotes T82	C0443343; Unstable status; Finding
R13	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T82	
T83	Quantifier_or_Qualifier 1603 1629	clínicamente significativa
R14	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T83	
R15	Negation Arg1:T65 Arg2:T30	
A23	Assertion T82 Speculated
R16	Speculation Arg1:T77 Arg2:T82	
R17	Speculation Arg1:T77 Arg2:T83	
A24	Assertion T83 Speculated
T84	Result_or_Value 1658 1667	positivos
#67	AnnotatorNotes T84	C1446409; Positive; Finding
R18	Has_Result_or_Value Arg1:T31 Arg2:T84	
R20	Location_of Arg1:T44 Arg2:T32	
R21	Location_of Arg1:T33 Arg2:T32	
T85	Quantifier_or_Qualifier 1747 1761	significativas
#68	AnnotatorNotes T85	C1546944; Event Seriousness - Significant; Qualitative Concept
R22	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T85	
R23	Causes Arg1:T29 Arg2:T35	
R24	Causes Arg1:T29 Arg2:T34	
R25	Used_for Arg1:T36 Arg2:T3	
R26	Before Arg1:T3 Arg2:T4	
R27	Negation Arg1:T49 Arg2:T7	
R28	Before Arg1:T3 Arg2:T7	
R29	Experiences Arg1:T47 Arg2:T3	
R34	Experiences Arg1:T48 Arg2:T3	
R35	Causes Arg1:T69 Arg2:T4	
R36	Causes Arg1:T73 Arg2:T6	
R37	Causes Arg1:T73 Arg2:T5	
R38	Has_Age Arg1:T50 Arg2:T51	
R39	Overlap Arg1:T51 Arg2:T78	
R40	Has_Quantifier_or_Qualifier Arg1:T78 Arg2:T79	
T86	Observation 577 601	cumplir con el protocolo
#69	AnnotatorNotes T86	C2364172; Adherence To Medication Regime; Finding (?)
R41	Before Arg1:T9 Arg2:T86	
R42	Causes Arg1:T74 Arg2:T10	
R43	Negation Arg1:T55 Arg2:T75	
T87	Result_or_Value 805 813	positiva
#70	AnnotatorNotes T87	C1446409; Positive; Finding
R44	Has_Result_or_Value Arg1:T37 Arg2:T87	
T88	Result_or_Value 830 838	positiva
#71	AnnotatorNotes T88	C1446409; Positive; Finding
R45	Has_Result_or_Value Arg1:T12 Arg2:T88	
#72	AnnotatorNotes T12	C0236416; Serum IgG Test; Laboratory Procedure
R46	Causes Arg1:T54 Arg2:T87	
R47	Causes Arg1:T54 Arg2:T88	
R48	Overlap Arg1:T12 Arg2:T38	
R49	Negation Arg1:T56 Arg2:T14	
R50	Overlap Arg1:T12 Arg2:T14	
R51	Causes Arg1:T75 Arg2:T87	
R52	Causes Arg1:T75 Arg2:T88	
R53	Overlap Arg1:T38 Arg2:T14	
R54	Used_for Arg1:T11 Arg2:T15	
R55	Used_for Arg1:T16 Arg2:T15	
R56	Overlap Arg1:T11 Arg2:T57	
R57	Overlap Arg1:T16 Arg2:T57	
R58	Overlap Arg1:T19 Arg2:T58	
R59	Used_for Arg1:T21 Arg2:T20	
R60	Used_for Arg1:T22 Arg2:T20	
R61	Overlap Arg1:T21 Arg2:T59	
R62	Overlap Arg1:T22 Arg2:T59	
R63	Location_of Arg1:T40 Arg2:T23	
R64	Location_of Arg1:T40 Arg2:T24	
R30	Has_Duration_or_Interval Arg1:T76 Arg2:T52	
R32	Has_Duration_or_Interval Arg1:T76 Arg2:T53	
#73	AnnotatorNotes T83	C5209294; Clinical relevance; Intellectual Product
R31	Experiences Arg1:T47 Arg2:T4	
R33	Experiences Arg1:T47 Arg2:T7	
R67	Experiences Arg1:T48 Arg2:T4	
R68	Experiences Arg1:T48 Arg2:T7	
R69	Causes Arg1:T69 Arg2:T7	
#74	AnnotatorNotes T79	C0205435; First (number); Quantitative Concept
R11	Causes Arg1:T43 Arg2:T84	
#75	AnnotatorNotes T10	C5397139; History of SARS-CoV-2; Finding
A25	Experiencer T47 Patient
A26	Experiencer T48 Patient
A27	Experiencer T73 Patient
A28	Experiencer T50 Patient
T89	Result_or_Value 857 865	negativa
R19	Has_Result_or_Value Arg1:T38 Arg2:T89	
